• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Noncigarette tobacco product use is associated with future cigarette smoking

byAngela ZhangandAnees Daud
January 4, 2018
in Chronic Disease
Reading Time: 3 mins read
Smoking associated with increased mortality in breast cancer patients
Share on FacebookShare on Twitter

1. Never-cigarette-smoking youths who initiated tobacco use with noncigarette products including e-cigarettes, hookahs, noncigarette combustible tobacco, or smokeless tobacco were more likely to smoke cigarettes in the following year than those who did not use noncigarette tobacco.

2. Association with future smoking was similar across different noncigarette products, and was similar whether product use was former or current. Additionally, use of multiple products was associated with a higher likelihood of initiation of cigarette use than use of a single product.

Evidence Rating Level: 2 (Good)

Study Rundown: Use of noncigarette tobacco products by youths has increased recently, and there is concern that this may lead to increase in cigarette smoking. Previous studies have demonstrated associations of use of individual products such as e-cigarettes, smokeless tobacco, and hookahs with future cigarette smoking. However, this study was the first to directly compare these products, as well as compare use of a single product to polyuse of noncigarette products. Using the Population Assessment of Tobacco and Health (PATH) study population consisting of youth ages 12 to 17 years, the investigators studied use of noncigarette tobacco products among youths who had never used cigarettes at baseline, and assessed ever and past 30-day use of cigarettes one year later. Results showed that odds of cigarette use approximately doubled for those who ever used e-cigarettes, hookah, noncigarette combustible tobacco, and smokeless tobacco. Polyuse of two or more noncigarette tobacco products was associated with greater odds of cigarette smoking.

While the study used a large, nationally representative sample, the observational design limits determination of causality. Though this study did not determine how noncigarette tobacco products increase cigarette use, whether by nicotine dependence, changing perception of cigarettes, social mediators, or other factors, it sheds light on the need for policy changes to limit use of noncigarette tobacco products and prevent health risks associated with it.

Click to read the study, published in JAMA Pediatrics

RELATED REPORTS

Alcohol use declines but remains above pre-pandemic levels

High maternal egg-peanut intake not associated with reduced infant allergy

The rotavirus vaccine (ROTASIIL) may reduce the incidence of hospitalization for rotavirus gastroenteritis in children

Relevant Reading: Assessing 30-day quantity-frequency of U.S. adolescent cigarette smoking as a predictor of adult smoking 14 years later.

In-Depth [cohort study]: This study used a sample of 10,384 never-cigarette-smoking youths of ages 12 to 17 years from the Population Assessment of Tobacco and Health (PATH) study to determine the association between noncigarette tobacco product use and later cigarette smoking. They studied ever, former, and past 30-day use of noncigarette tobacco products in 4 categories: e-cigarettes, hookah, noncigarette combustible tobacco (bidis, cigarillos, filtered cigars, kreteks, pipes, and traditional cigars), and smokeless tobacco at baseline. One year later, they surveyed the same individuals about ever and past 30-day use of cigarettes.

The results were adjusted for sex, age, race/ethnicity, parental educational level, and urban residence to account for variation across sociodemographic groups. Results demonstrated that cigarette use initiation was associated with ever use of e-cigarettes (OR, 2.53; 95%CI, 1.80-3.56), hookah (OR, 1.79; 95%CI, 1.23-2.62), noncigarette combustible tobacco (OR, 1.64; 95%CI, 1.06-2.54), and smokeless tobacco (OR, 1.66; 95%CI, 1.00-2.76). Similar results were obtained for past 30-day cigarette use, and for both former and past 30-day use of each noncigarette tobacco product. Furthermore, baseline ever exclusive use (ever only use of a single noncigarette tobacco product) was also positively associated with cigarette smoking initiation, with the exception of smokeless tobacco, which was positively associated but not statistically significant (OR, 1.53; 95%CI, 0.56-4.19). Additionally, polyuse of tobacco products was associated with a greater risk for cigarette smoking initiation (OR, 3.95; 95%CI, 2.65-5.90) and past 30-day cigarette use (OR, 3.81; 95%CI, 2.22-6.54).

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Previous Post

Systemic atherosclerosis linked with intracranial atherosclerotic disease-related stroke and worse prognosis

Next Post

Thrombectomy between 6 and 24 hours after acute stroke reduces disability: The DAWN trial

RelatedReports

Psychiatry

Alcohol use declines but remains above pre-pandemic levels

September 22, 2026
Chronic Disease

High maternal egg-peanut intake not associated with reduced infant allergy

September 22, 2026
Emergency

The rotavirus vaccine (ROTASIIL) may reduce the incidence of hospitalization for rotavirus gastroenteritis in children

September 21, 2026
Artificial Intelligence

Emergency department triaging decisions supported by artificial intelligence (AI) led to improved triaging accuracy and patient flow

September 21, 2026
Next Post
Intensive rehabilitation not superior to traditional therapy for arm function after stroke

Thrombectomy between 6 and 24 hours after acute stroke reduces disability: The DAWN trial

Microcephaly rates elevated in Brazil prior to Zika virus epidemic

Microcephaly rates elevated in Brazil prior to Zika virus epidemic

AAP supports mandatory influenza vaccination of health care providers

Herpes zoster subunit vaccine may be more cost-effective than live attenuated zoster vaccine

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Alcohol use declines but remains above pre-pandemic levels
  • High maternal egg-peanut intake not associated with reduced infant allergy
  • The rotavirus vaccine (ROTASIIL) may reduce the incidence of hospitalization for rotavirus gastroenteritis in children
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.